Engineering 2D Arsenic‐Phosphorus Theranostic Nanosheets
- 15 April 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (25) , 2101660
Abstract
As an anticancer drugs, arsenic trioxide (ATO) has been certified to efficiently treat refractory acute promyelocytic leukemia (APL). Unfortunately it suffers from limited therapeutic potency for solid tumors due to its in vivo restricted administration dose and rapid renal clearance. Herein, distinct 2D arsenic‐phosphorus (AsP) nanosheets are engineered by adopting an alloy strategy followed by exfoliation, which can confine toxic arsenic into AsP crystals, thus significantly improving the biosafety and biocompatibility of arsenic‐based chemotherapeutic drugs. Of particular note, the high light absorption and strong photothermal‐conversion efficiency (37.6%) in the second near infrared biowindow (NIR‐II) of AsP nanosheets not only endow them with desirable contrast‐enhanced photoacoustic imaging properties, but also achieve efficient local tumor hyperthermia, which further synergistically triggers the in‐situ transformation from low toxic/nontoxic AsP crystals into highly toxic arsenic species, exerting a strong arsenic‐mediated antineoplastic effect. Both in vitro and in vivo data verify the synergy between photonic therapy in NIR‐II and enhanced chemotherapy as enabled by AsP nanosheets, paving the way for efficient nanomedicine‐enabled arsenic‐based chemotherapeutic tumor treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81871361, 81571693, 81401428, 82003182)
This publication has 71 references indexed in Scilit:
- Chemically Exfoliated MoS2 as Near‐Infrared Photothermal AgentsAngewandte Chemie International Edition, 2013
- Synthesis and Identification of Metastable Compounds: Black Arsenic—Science or Fiction?Angewandte Chemie International Edition, 2012
- Freestanding palladium nanosheets with plasmonic and catalytic propertiesNature Nanotechnology, 2010
- Acute promyelocytic leukaemia: novel insights into the mechanisms of cureNature Reviews Cancer, 2010
- Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PMLScience, 2010
- Biological Responses to Arsenic CompoundsJournal of Biological Chemistry, 2009
- Microscale Heat Transfer Transduced by Surface Plasmon Resonant Gold NanoparticlesThe Journal of Physical Chemistry C, 2007
- Arsenic: Signal Transduction, Transcription Factor, and Biotransformation Involved in Cellular Response and ToxicityAnnual Review of Pharmacology and Toxicology, 2007
- Lipid Encapsulation of Arsenic Trioxide Attenuates Cytotoxicity and Allows for Controlled Anticancer Drug ReleaseJournal of the American Chemical Society, 2006
- Phase transitions and superconductivity of black phosphorus and phosphorus-arsenic alloys at low temperatures and high pressuresPhysical Review B, 1994